Too many people with sickle cell disease are dying preventable deaths. This negligence must end, columnist Mary Shaniqua says ...

Clinton Health Access Initiative will use award to expand access to SCD diagnostic tests and treatment in low- and ...

Cyclosporin H boosts a new lentivirus-delivered gene therapy with enhanced anti-sickling properties in blood stem cells from ...

Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.

In a society that often treats those living with a disability as "less than," columnist Mary Shaniqua reminds her community ...

A University of Rochester hospital will open a patient study comparing the efficacy of SCD treatments to help families in ...

It may be possible to collect nearly three times as many stem cells for sickle cell gene therapy with motixafortide than standard plerixafor.